Back to Blog
Peptide Policy••9 min read
BPC-157 and the 2026 Regulatory Shift: What the HHS Category 1 Push Means for Peptide Access
After years of regulatory limbo, BPC-157 is at the center of a major policy battle. The RFK Jr.-led HHS push to reclassify it as Category 1 could restore legal compounding access—or the FDA could dig in. Here's where things stand.
PeptIQ Research Team
Editorial
#HHS#compound-pharmacy#BPC-157#Compounding#FDA#Peptide Regulation#RFK#policy-2026
Track Your Peptide Protocols
Use PeptIQ to log injections, calculate doses, access our peptide library, and optimize your protocols.
Download PeptIQ
